Correction to: Understanding Clinician Preferences for Treatment Attributes in Oncology: A Discrete Choice Experiment of Oncologists' and Urologists' Preferences for First-Line Treatment of Locally Advanced/Unresectable Metastatic Urothelial Carcinoma in Five European Countries.

Panattoni, Laura; Kearney, Mairead; Land, Natalie; Flottemesch, Thomas; Sullivan, Patrick; Kirker, Melissa; Bharmal, Murtuza; Hauber, Brett

Panattoni, Laura; Kearney, Mairead; Land, Natalie; Flottemesch, Thomas; Sullivan, Patrick; Kirker, Melissa; Bharmal, Murtuza; Hauber, Brett.

Afiliación

Panattoni L; PRECISIONheor, New York, NY, USA. laura.panattoni@precisionvh.com.
Kearney M; Merck Healthcare KGaA, Darmstadt, Germany.
Land N; PRECISIONheor, New York, NY, USA.
Flottemesch T; PRECISIONheor, New York, NY, USA.
Sullivan P; PRECISIONheor, New York, NY, USA.
Kirker M; Pfizer, New York, NY, USA.
Bharmal M; EMD Serono, Research & Development Institute, Inc., Billerica, MA, USA.
Hauber B; Pfizer, New York, NY, USA.

Pharmacoeconomics ; 42(8): 911, 2024 Aug.

Article en En | MEDLINE | ID: mdl-38874847

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Pharmacoeconomics Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google